| ▲ | cosmotic 2 hours ago | |||||||
Is it normal to not report how many people received the treatment and just report the number of successes? Is this better than placebo or doing nothing? | ||||||||
| ▲ | goda90 an hour ago | parent | next [-] | |||||||
It sounds like it might've been the first three people to receive the treatment at all. 15 more are going to be given higher doses next to hunt for an optimum level. I think with trials involving experimental life saving treatment for terminal illnesses, doing things like control groups and placebos isn't considered particularly ethical, since you'd be giving false hope to someone who is knocking on death's door. | ||||||||
| ||||||||
| ▲ | HedonicEscal8r an hour ago | parent | prev | next [-] | |||||||
It's normal for a Phase 1 trial, which evaluates safety and dosing on a small number of participants. If the drug passes, more extensive trials will be done. | ||||||||
| ▲ | nutjob2 an hour ago | parent | prev [-] | |||||||
Why test against a placebo when you can test against death? Although not 100%, almost all terminal patients will die. If you select your test group well so they are very likely to die, then you improve the information you get from the test, favor the class of patients who are most likely to benefit from the treatment and least likely to be harmed by it overall. | ||||||||